BLTE, NCM
Belite Bio, Inc (BLTE)
Price (as of October 27)
27.81USD
Correlations
Lowest within Industry
| Symbol | Correlation |
|---|---|
|
AC Immune SA |
-0.31 |
|
Alector, Inc. |
-0.26 |
|
Aptorum Group Limited |
-0.24 |
|
Acumen Pharmaceuticals, Inc. |
-0.21 |
|
Arcellx, Inc. |
-0.2 |
|
AN2 Therapeutics, Inc. |
-0.19 |
|
ARCA biopharma, Inc. |
-0.1 |
|
BioNTech SE |
-0.18 |
|
Adverum Biotechnologies, Inc. |
0.11 |
|
Apellis Pharmaceuticals, Inc. |
-0.18 |
Highest within Industry
| Symbol | Correlation |
|---|---|
|
Bellicum Pharmaceuticals, Inc. |
0.2 |
|
Albireo Pharma, Inc. |
0.2 |
|
ASLAN Pharmaceuticals Limited |
0.19 |
|
Applied Therapeutics, Inc. |
0.18 |
|
Arcutis Biotherapeutics, Inc. |
0.15 |
|
Aridis Pharmaceuticals, Inc. |
0.15 |
|
Achieve Life Sciences, Inc. |
-0.06 |
|
Allogene Therapeutics, Inc. |
0.15 |
|
Annexon, Inc. |
0.13 |
|
Acasti Pharma Inc. |
0.06 |
Lowest within Industry
| Symbol | Correlation |
|---|---|
|
Aptorum Group Limited |
-0.24 |
|
AN2 Therapeutics, Inc. |
-0.19 |
|
BioNTech SE |
-0.18 |
|
Apellis Pharmaceuticals, Inc. |
-0.18 |
|
Athira Pharma, Inc. |
-0.17 |
|
Absci Corporation |
-0.17 |
|
Adicet Bio, Inc. |
-0.16 |
|
180 Life Sciences Corp. |
-0.15 |
|
Moderna, Inc. |
-0.15 |
|
Atea Pharmaceuticals, Inc. |
-0.15 |
Highest within Industry
| Symbol | Correlation |
|---|---|
|
Bellicum Pharmaceuticals, Inc. |
0.2 |
|
ASLAN Pharmaceuticals Limited |
0.19 |
|
Applied Therapeutics, Inc. |
0.18 |
|
Allogene Therapeutics, Inc. |
0.15 |
|
Arcutis Biotherapeutics, Inc. |
0.15 |
|
Aridis Pharmaceuticals, Inc. |
0.15 |
|
Alnylam Pharmaceuticals, Inc. |
0.14 |
|
Alpine Immune Sciences, Inc. |
0.13 |
|
Annexon, Inc. |
0.13 |
|
Avenue Therapeutics, Inc. |
0.12 |
Lowest within Industry
| Symbol | Correlation |
|---|---|
|
Aptorum Group Limited |
-0.24 |
|
AN2 Therapeutics, Inc. |
-0.19 |
|
BioNTech SE |
-0.18 |
|
Apellis Pharmaceuticals, Inc. |
-0.18 |
|
Athira Pharma, Inc. |
-0.17 |
|
Absci Corporation |
-0.17 |
|
Adicet Bio, Inc. |
-0.16 |
|
180 Life Sciences Corp. |
-0.15 |
|
Moderna, Inc. |
-0.15 |
|
Atea Pharmaceuticals, Inc. |
-0.15 |
Highest within Industry
| Symbol | Correlation |
|---|---|
|
Bellicum Pharmaceuticals, Inc. |
0.2 |
|
ASLAN Pharmaceuticals Limited |
0.19 |
|
Applied Therapeutics, Inc. |
0.18 |
|
Allogene Therapeutics, Inc. |
0.15 |
|
Arcutis Biotherapeutics, Inc. |
0.15 |
|
Aridis Pharmaceuticals, Inc. |
0.15 |
|
Alnylam Pharmaceuticals, Inc. |
0.14 |
|
Alpine Immune Sciences, Inc. |
0.13 |
|
Annexon, Inc. |
0.13 |
|
Avenue Therapeutics, Inc. |
0.12 |
Lowest within Industry
| Symbol | Correlation |
|---|---|
|
Aptorum Group Limited |
-0.24 |
|
AN2 Therapeutics, Inc. |
-0.19 |
|
BioNTech SE |
-0.18 |
|
Apellis Pharmaceuticals, Inc. |
-0.18 |
|
Athira Pharma, Inc. |
-0.17 |
|
Absci Corporation |
-0.17 |
|
Adicet Bio, Inc. |
-0.16 |
|
180 Life Sciences Corp. |
-0.15 |
|
Moderna, Inc. |
-0.15 |
|
Atea Pharmaceuticals, Inc. |
-0.15 |
Highest within Industry
| Symbol | Correlation |
|---|---|
|
Bellicum Pharmaceuticals, Inc. |
0.2 |
|
ASLAN Pharmaceuticals Limited |
0.19 |
|
Applied Therapeutics, Inc. |
0.18 |
|
Allogene Therapeutics, Inc. |
0.15 |
|
Arcutis Biotherapeutics, Inc. |
0.15 |
|
Aridis Pharmaceuticals, Inc. |
0.15 |
|
Alnylam Pharmaceuticals, Inc. |
0.14 |
|
Alpine Immune Sciences, Inc. |
0.13 |
|
Annexon, Inc. |
0.13 |
|
Avenue Therapeutics, Inc. |
0.12 |
Lowest by Sector
| Symbol | Correlation |
|---|---|
|
Bluejay Diagnostics, Inc. |
-0.37 |
|
AC Immune SA |
-0.31 |
|
Accolade, Inc. |
-0.31 |
|
Gilead Sciences, Inc. |
-0.29 |
|
AmerisourceBergen Corporation |
-0.29 |
|
Alkermes plc |
-0.27 |
|
Biocept, Inc. |
-0.27 |
|
Teladoc Health, Inc. |
-0.27 |
|
Babylon Holdings Limited |
-0.26 |
|
Alector, Inc. |
-0.14 |
Highest by Sector
| Symbol | Correlation |
|---|---|
|
Amneal Pharmaceuticals, Inc. |
0.31 |
|
GSK plc |
0.31 |
|
Augmedix, Inc. |
0.27 |
|
AstraZeneca PLC |
0.26 |
|
Hikma Pharmaceuticals PLC |
0.21 |
|
Bellicum Pharmaceuticals, Inc. |
0.2 |
|
Albireo Pharma, Inc. |
0.05 |
|
ASLAN Pharmaceuticals Limited |
0.19 |
|
Bright Health Group, Inc. |
0.19 |
|
Applied Therapeutics, Inc. |
0.18 |
Lowest by Sector
| Symbol | Correlation |
|---|---|
|
Bluejay Diagnostics, Inc. |
-0.37 |
|
AmerisourceBergen Corporation |
-0.32 |
|
Gilead Sciences, Inc. |
-0.29 |
|
Biocept, Inc. |
-0.27 |
|
Alkermes plc |
-0.27 |
|
Teladoc Health, Inc. |
-0.27 |
|
Babylon Holdings Limited |
-0.26 |
|
23andMe Holding Co. |
-0.24 |
|
Aptorum Group Limited |
-0.24 |
|
Alcon Inc. |
-0.23 |
Highest by Sector
| Symbol | Correlation |
|---|---|
|
GSK plc |
0.31 |
|
Augmedix, Inc. |
0.27 |
|
AstraZeneca PLC |
0.26 |
|
Hikma Pharmaceuticals PLC |
0.21 |
|
Bellicum Pharmaceuticals, Inc. |
0.2 |
|
ASLAN Pharmaceuticals Limited |
0.19 |
|
Bright Health Group, Inc. |
0.19 |
|
Applied Therapeutics, Inc. |
0.18 |
|
BIOLASE, Inc. |
0.16 |
|
Biodesix, Inc. |
0.16 |
Lowest by Sector
| Symbol | Correlation |
|---|---|
|
Bluejay Diagnostics, Inc. |
-0.37 |
|
AmerisourceBergen Corporation |
-0.32 |
|
Gilead Sciences, Inc. |
-0.29 |
|
Biocept, Inc. |
-0.27 |
|
Alkermes plc |
-0.27 |
|
Teladoc Health, Inc. |
-0.27 |
|
Babylon Holdings Limited |
-0.26 |
|
23andMe Holding Co. |
-0.24 |
|
Aptorum Group Limited |
-0.24 |
|
Alcon Inc. |
-0.23 |
Highest by Sector
| Symbol | Correlation |
|---|---|
|
GSK plc |
0.31 |
|
Augmedix, Inc. |
0.27 |
|
AstraZeneca PLC |
0.26 |
|
Hikma Pharmaceuticals PLC |
0.21 |
|
Bellicum Pharmaceuticals, Inc. |
0.2 |
|
ASLAN Pharmaceuticals Limited |
0.19 |
|
Bright Health Group, Inc. |
0.19 |
|
Applied Therapeutics, Inc. |
0.18 |
|
BIOLASE, Inc. |
0.16 |
|
Biodesix, Inc. |
0.16 |
Lowest by Sector
| Symbol | Correlation |
|---|---|
|
Bluejay Diagnostics, Inc. |
-0.37 |
|
AmerisourceBergen Corporation |
-0.32 |
|
Gilead Sciences, Inc. |
-0.29 |
|
Biocept, Inc. |
-0.27 |
|
Alkermes plc |
-0.27 |
|
Teladoc Health, Inc. |
-0.27 |
|
Babylon Holdings Limited |
-0.26 |
|
23andMe Holding Co. |
-0.24 |
|
Aptorum Group Limited |
-0.24 |
|
Alcon Inc. |
-0.23 |
Highest by Sector
| Symbol | Correlation |
|---|---|
|
GSK plc |
0.31 |
|
Augmedix, Inc. |
0.27 |
|
AstraZeneca PLC |
0.26 |
|
Hikma Pharmaceuticals PLC |
0.21 |
|
Bellicum Pharmaceuticals, Inc. |
0.2 |
|
ASLAN Pharmaceuticals Limited |
0.19 |
|
Bright Health Group, Inc. |
0.19 |
|
Applied Therapeutics, Inc. |
0.18 |
|
BIOLASE, Inc. |
0.16 |
|
Biodesix, Inc. |
0.16 |
Lowest Overall
| Symbol | Correlation |
|---|---|
|
Banco Bilbao Vizcaya Argentaria, S.A. |
-0.51 |
|
Argo Group International Holdings, Ltd. |
-0.44 |
|
Athena Technology Acquisition Corp. II |
-0.41 |
|
Avantor, Inc. |
-0.4 |
|
Air Transport Services Group, Inc. |
-0.4 |
|
AltEnergy Acquisition Corp. |
-0.04 |
|
Comcast Corporation |
-0.38 |
|
SPDR Bloomberg 3-12 Month T-Bill ETF |
-0.37 |
|
Bluejay Diagnostics, Inc. |
-0.37 |
|
Blackboxstocks Inc. |
-0.37 |
Highest Overall
| Symbol | Correlation |
|---|---|
|
Apollo Strategic Growth Capital II |
0.39 |
|
Battery Future Acquisition Corp. |
0.38 |
|
B&G Foods, Inc. |
0.32 |
|
Amneal Pharmaceuticals, Inc. |
0.31 |
|
GSK plc |
0.31 |
|
Waste Management, Inc. |
0.27 |
|
Autoliv, Inc. |
0.02 |
|
Augmedix, Inc. |
0.27 |
|
AstraZeneca PLC |
0.26 |
|
The Sherwin-Williams Company |
0.25 |
Lowest Overall
| Symbol | Correlation |
|---|---|
|
Banco Bilbao Vizcaya Argentaria, S.A. |
-0.51 |
|
Argo Group International Holdings, Ltd. |
-0.44 |
|
Athena Technology Acquisition Corp. II |
-0.41 |
|
Avantor, Inc. |
-0.4 |
|
Air Transport Services Group, Inc. |
-0.4 |
|
Comcast Corporation |
-0.38 |
|
SPDR Bloomberg 3-12 Month T-Bill ETF |
-0.37 |
|
Bluejay Diagnostics, Inc. |
-0.37 |
|
Blackboxstocks Inc. |
-0.37 |
|
A. O. Smith Corporation |
-0.37 |
Highest Overall
| Symbol | Correlation |
|---|---|
|
Apollo Strategic Growth Capital II |
0.39 |
|
Battery Future Acquisition Corp. |
0.38 |
|
B&G Foods, Inc. |
0.32 |
|
GSK plc |
0.31 |
|
Waste Management, Inc. |
0.27 |
|
Augmedix, Inc. |
0.27 |
|
AstraZeneca PLC |
0.26 |
|
The Sherwin-Williams Company |
0.25 |
|
Build Acquisition Corp. |
0.25 |
|
American International Group, Inc. |
0.24 |
Lowest Overall
| Symbol | Correlation |
|---|---|
|
Banco Bilbao Vizcaya Argentaria, S.A. |
-0.51 |
|
Argo Group International Holdings, Ltd. |
-0.44 |
|
Athena Technology Acquisition Corp. II |
-0.41 |
|
Avantor, Inc. |
-0.4 |
|
Air Transport Services Group, Inc. |
-0.4 |
|
Comcast Corporation |
-0.38 |
|
SPDR Bloomberg 3-12 Month T-Bill ETF |
-0.37 |
|
Bluejay Diagnostics, Inc. |
-0.37 |
|
Blackboxstocks Inc. |
-0.37 |
|
A. O. Smith Corporation |
-0.37 |
Highest Overall
| Symbol | Correlation |
|---|---|
|
Apollo Strategic Growth Capital II |
0.39 |
|
Battery Future Acquisition Corp. |
0.38 |
|
B&G Foods, Inc. |
0.32 |
|
GSK plc |
0.31 |
|
Waste Management, Inc. |
0.27 |
|
Augmedix, Inc. |
0.27 |
|
AstraZeneca PLC |
0.26 |
|
The Sherwin-Williams Company |
0.25 |
|
Build Acquisition Corp. |
0.25 |
|
American International Group, Inc. |
0.24 |
Lowest Overall
| Symbol | Correlation |
|---|---|
|
Banco Bilbao Vizcaya Argentaria, S.A. |
-0.51 |
|
Argo Group International Holdings, Ltd. |
-0.44 |
|
Athena Technology Acquisition Corp. II |
-0.41 |
|
Avantor, Inc. |
-0.4 |
|
Air Transport Services Group, Inc. |
-0.4 |
|
Comcast Corporation |
-0.38 |
|
SPDR Bloomberg 3-12 Month T-Bill ETF |
-0.37 |
|
Bluejay Diagnostics, Inc. |
-0.37 |
|
Blackboxstocks Inc. |
-0.37 |
|
A. O. Smith Corporation |
-0.37 |
Highest Overall
| Symbol | Correlation |
|---|---|
|
Apollo Strategic Growth Capital II |
0.39 |
|
Battery Future Acquisition Corp. |
0.38 |
|
B&G Foods, Inc. |
0.32 |
|
GSK plc |
0.31 |
|
Waste Management, Inc. |
0.27 |
|
Augmedix, Inc. |
0.27 |
|
AstraZeneca PLC |
0.26 |
|
The Sherwin-Williams Company |
0.25 |
|
Build Acquisition Corp. |
0.25 |
|
American International Group, Inc. |
0.24 |
Profile
- Sector:
- Healthcare
- Industry:
- Biotechnology
Belite Bio, Inc, a clinical-stage biopharmaceutical drug development company, engages in the research and development of novel therapeutics targeting atrophic age-related macular degeneration and autosomal recessive stargardt diseases. Its lead product candidate is LBS-008, an oral once-a-day treatment that can reduce and maintain the delivery of vitamin A to the eye to reduce the accumulation of toxic vitamin A by-products in ocular tissue that is in phase 3 clinical trial. The company is also developing LBS-009, an anti-retinol binding protein 4 oral therapy targeting liver disease, including non-alcoholic fatty liver disease, nonalcoholic steatohepatitis, and type 2 diabetes, which is in the preclinical development phase. Belite Bio, Inc was founded in 2016 and is based in San Diego, California. Belite Bio, Inc operates as a subsidiary of Lin Bioscience International Ltd.